{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:46:56Z","timestamp":1767854816750,"version":"3.49.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Currently, there is no validated model for predicting the occurrence and prognosis of lung metastases (LM) in patients with pancreatic ductal adenocarcinoma (PDAC). We aimed to construct a nomogram for risk prediction and a prognostic model to guide clinical practice. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 10,813 patients were enrolled from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015 and divided into training and internal validation cohorts at a ratio of 7:3. Following nomogram construction, data of patients diagnosed with PDAC were retrospectively collected for external validation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using multivariate logistic regression analysis, larger tumour size, primary tumour site in the body or tail of the pancreas, bone metastasis, and liver metastasis were associated with LM. Furthermore, through multivariate Cox analysis, we found that LM was associated with a poor prognosis in patients with PDAC. Patients who underwent surgery or chemotherapy had better prognoses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The two nomograms showed excellent performance in the training and internal validation cohorts and a favourable performance in the external validation. The prognostic nomogram divided the patients into high- and low-risk groups based on mortality. The LM risk and prognostic prediction model in PDAC showed high accuracy and reliable clinical application.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1521616","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:10:47Z","timestamp":1747800647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study"],"prefix":"10.3389","volume":"15","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianshui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengsheng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangnian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2020.02.011","article-title":"Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017","volume":"20","author":"Chen","year":"2020","journal-title":"Pancreatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.3390\/cancers15112923","article-title":"PDAC, the influencer cancer: cross-talk with tumor microenvironment and connected potential therapy strategies","volume":"15","author":"Mercanti","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: A review","volume":"326","author":"Park","year":"2021","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.24875\/ciru.22000364","article-title":"Current status of pancreatic cancer with oligometastasis","volume":"91","author":"Chapa-Azuela","year":"2023","journal-title":"Cir Cir"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2198479","DOI":"10.1080\/15384047.2023.2198479","article-title":"Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence","volume":"24","author":"Adekolujo","year":"2023","journal-title":"Cancer Biol Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2017.04.006","article-title":"Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer","volume":"44","author":"Giovannetti","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5751","article-title":"Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival","volume":"12","author":"Ebrahimi","year":"2023","journal-title":"Cancer Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018171670","article-title":"Pancreatic adenocarcinoma staging in the era of preoperative chemotherapy and radiation therapy","volume":"287","author":"Zins","year":"2018","journal-title":"Radiology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06140-9","article-title":"MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer","volume":"29","author":"Bae","year":"2019","journal-title":"Eur Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.15.15236","article-title":"Presurgical evaluation of pancreatic cancer: A comprehensive imaging comparison of CT versus MRI","volume":"206","author":"Chen","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-014-0473-1","article-title":"(18)F-FDG-PET\/CT findings in pancreatic metastasis","volume":"120","author":"Hu","year":"2015","journal-title":"Radiol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1386699","article-title":"Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments","volume":"14","author":"Bugazia","year":"2024","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2019.1670063","article-title":"Liquid biopsies in pancreatic cancer","volume":"19","author":"Kamyabi","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"B17","article-title":"Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening","volume-title":"Pancreatic Cancer","author":"Abdullah","year":"2023"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.1127","article-title":"Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis","volume":"29","author":"Homma","year":"2022","journal-title":"J Hepatobil Pancreat Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204310","article-title":"A comprehensive review of pancreatic cancer and its therapeutic challenges","volume":"14","author":"Jiang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2022.08.010","article-title":"Regulation of pancreatic cancer therapy resistance by chemokines","volume":"86","author":"Gautam","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40779-023-00488-2","article-title":"How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology","volume":"10","author":"Che","year":"2023","journal-title":"Mil Med Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"B24","article-title":"Nomogram as predictive model in clinical practice","volume":"36","author":"Ohori Tatsuo","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.997713","article-title":"From past to future: Bibliometric analysis of global research productivity on nomogram (2000-2021)","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.07.1290","article-title":"Are nomograms better than currently available stage groupings for bladder cancer","volume":"24","author":"Sternberg","year":"2006","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"101821","DOI":"10.1016\/j.semerg.2022.101821","article-title":"ROC curve","volume":"49","author":"Mart\u00ednez P\u00e9rez","year":"2023","journal-title":"Semergen"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.65.5654","article-title":"Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use","volume":"34","author":"Kerr","year":"2016","journal-title":"J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.37","article-title":"Decision curve analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2017.11.018","article-title":"A discussion of calibration techniques for evaluating binary and categorical predictive models","volume":"149","author":"Fenlon","year":"2018","journal-title":"Prev Vet Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01823-7","article-title":"Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making","volume":"28","author":"Zhu","year":"2023","journal-title":"Apoptosis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3390\/cancers12071955","article-title":"Advanced pancreatic ductal adenocarcinoma: moving forward","volume":"12","author":"Franck","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejca.2018.10.008","article-title":"Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis","volume":"106","author":"Mackay","year":"2019","journal-title":"Eur J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10471","article-title":"Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma","volume":"104","author":"Ansari","year":"2017","journal-title":"Br J Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/cancers14092067","article-title":"Can surgical resection of metastatic lesions be beneficial to pancreatic ductal adenocarcinoma patients with isolated lung metastasis","volume":"14","author":"Yun","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12893-021-01236-w","article-title":"Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study","volume":"21","author":"Mashiko","year":"2021","journal-title":"BMC Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.3390\/cancers15245881","article-title":"Therapy of locally advanced and oligometastatic pancreatic adenocarcinoma","volume":"15","author":"Wahler","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12613","article-title":"Prognostic factors in conversion surgery following nab-paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual-center study","volume":"7","author":"Igarashi","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10772","article-title":"Defining the molecular pathology of pancreatic body and tail adenocarcinoma","volume":"105","author":"Dreyer","year":"2018","journal-title":"Br J Surg"},{"key":"B41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41698-024-00571-4","article-title":"Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail","volume":"8","author":"Abdelrahim","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae155","article-title":"Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma","volume":"29","author":"Botta","year":"2024","journal-title":"Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1521616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:10:48Z","timestamp":1747800648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1521616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":42,"alternative-id":["10.3389\/fonc.2025.1521616"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1521616","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"article-number":"1521616"}}